Sukhtian Faisal Ghiath

CIK 00017160331 companyAMMAN, M2

SEC Profile

Transactions

Companies

Filings

CIK

0001716033

Recent Transactions

32 trades

Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2025-10-03+117,296→ 117,296 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2025-10-01+286,734→ 286,734 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2025-02-04+12,323→ 12,323 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-03+19,771→ 19,771 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+56,636→ 56,636 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+134,430→ 134,430 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-03-07+94,441→ 94,441 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-10-04+372,671→ 372,671 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-03-29+41,065→ 41,065 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-10-07$1.29/sh+30,000→ 68,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-10-05+74,878→ 74,878 total
Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-04-21+27,982,529→ 55,816,786 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-03-23+21,878→ 21,878 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-12-02$1.40/sh+18,000→ 38,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-10-05+44,753→ 44,753 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-04-19$1.82/sh+10,000→ 20,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-03-24+20,873→ 20,873 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-05$0.51/sh+151,721→ 151,721 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-01+296,352→ 296,352 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-09-17$0.67/sh+10,000→ 10,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-17+135,000→ 135,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-03-19+15,000→ 15,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2019-10-03+15,000→ 15,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2019-10-03$0.99/sh+86,772→ 86,772 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-02-01$0.93/sh+4,288,624→ 65,770,503 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-01-02$0.93/sh+4,288,624→ 61,481,879 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-12-31+1,505→ 61,708 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-12-03$0.93/sh+4,288,624→ 57,193,255 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-11-07$0.93/sh+8,577,248→ 52,904,631 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-09-30+1,468→ 60,203 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-09-30+1,648→ 60,383 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2017-10-31+25,000→ 25,000 total

Companies

Outlook Therapeutics, Inc.
Director
$OTLK

Recent Filings

Address

7TH CIRCLE, ZAHRAN ST. ZAHRAN PLAZA BLDG,4TH FLR, PO BOX 142909

AMMAN, M2, 11844

View on SEC.gov